Oxaliplatin Injection shortage
To Be Discontinued 6 presentations · 3 manufacturers · first FDA posting Oct 20, 2025 · last update Jun 29, 2026
Manufacturers: Fresenius Kabi USA, LLC, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Sandoz Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10) | Fresenius Kabi USA, LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Feb 25, 2026 Updated Feb 25, 2026 Discontinued Feb 25, 2026 |
| Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20) | Fresenius Kabi USA, LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Feb 25, 2026 Updated Feb 25, 2026 Discontinued Feb 25, 2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug | Posted Jun 29, 2026 Updated Jun 29, 2026 Discontinued Jun 29, 2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug | Posted Jun 29, 2026 Updated Jun 29, 2026 Discontinued Jun 29, 2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 20, 2025 Updated Oct 20, 2025 Discontinued Oct 20, 2025 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Oct 20, 2025 Updated Oct 20, 2025 Discontinued Oct 20, 2025 |